Floatz logo

cd70-targeting car-t cells

Anaplastic Thyroid Carcinomas

Chongqing Precision Biotech Co., LtdCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Anaplastic Thyroid Carcinomas cohort.

Asset / SponsorPhaseRating
gsk1120212
Cancer Research UK
Phase 2/3B
Dabrafenib
Cancer Research UK
Phase 2/3B
Cobimetinib
Cancer Research UK
Phase 2/3B
VEMURAFENIB
Cancer Research UK
Phase 2/3CCC
Nivolumab
M.D. Anderson Cancer Center
Phase 2CCC

View all 24 →

Same molecule, other indications

cd70-targeting car-t cells is also rated in:

lymphomaDormant
CC
Indicative ·
46 / 100
View asset →
metastatic neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
cervical cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →